Leah Freeman
Family · Connersville, INNPI 1205343795
Payments from drug & device makers
Across 325 payments — averaging $16.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$507
- Lilly USA, LLC$338
- Pfizer$334
- GSK$270
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$266
- plus $2K from 32 others
What the payments were for
- Food & beverage$5,17199%
- Education$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 85 | $1,381 |
| Otsuka America Pharmaceutical, Inc. | 36 | $507 |
| Lilly USA, LLC | 22 | $338 |
| Pfizer | 21 | $334 |
| GSK | 19 | $270 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $266 |
| Vanda Pharmaceuticals Inc. | 15 | $250 |
| Novo Nordisk | 10 | $154 |
| Axsome Therapeutics, Inc. | 8 | $149 |
| Amgen | 9 | $147 |
| Lundbeck LLC | 7 | $125 |
| Abbott | 7 | $113 |
| Neurocrine Biosciences, Inc. | 6 | $112 |
| Bayer | 5 | $92 |
| Astellas Pharma US Inc | 4 | $86 |
| Corium, LLC | 6 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $83 |
| Ironshore Pharmaceuticals Inc. | 5 | $78 |
| Amarin Pharma, Inc. | 4 | $67 |
| Mylan Specialty L.p. | 3 | $65 |
| AstraZeneca | 5 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Sanofi Pasteur Inc. | 4 | $55 |
| Exact Sciences | 3 | $50 |
| Biohaven Pharmaceuticals, Inc. | 3 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $29 |
| Novartis | 2 | $27 |
| Inari Medical, Inc. | 1 | $27 |
| Ascensia Diabetes Care US Inc. | 1 | $26 |
| Verona Pharma, Inc. | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Watermark Medical, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Organon | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Halozyme Inc | 1 | $13 |
How this compares
$5,230 in reported general payments places this provider in the 90th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 58 | $67,883 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 41 | $45,000 |
| FarxigaDapagliflozin Propanediol | 31 | $43,198 |
| MounjaroTirzepatide | 37 | $38,794 |
| RexultiBrexpiprazole | 16 | $37,356 |
| EliquisApixaban | 29 | $21,393 |
| JardianceEmpagliflozin | 14 | $19,630 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $15,743 |
| TrulicityDulaglutide | 12 | $11,814 |
| Emgality PenGalcanezumab-Gnlm | 11 | $9,436 |
| Humalog Kwikpen U-100Insulin Lispro | 22 | $8,727 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $8,264 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 23 | $3,548 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 151 | $2,933 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $2,278 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $154 | $67,88358 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $270 | $53,26455 claims |
| Lilly USA, LLCMounjaro, Trulicity | $338 | $50,60849 claims |
| AstraZenecaFarxiga | $63 | $43,19831 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $507 | $37,35616 claims |
| PfizerEliquis | $334 | $21,39329 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,392 family providers in Indiana.
Other family in Connersville
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.